continuing education, physical therapy, occupational therapy -

Printer Friendly Copy

Pharmacology for Physical Therapists Module 3

Format(s):   Home-study
Discipline(s):   Physical Therapy / Occupational Therapy
Contact Hours:   10
Registration Fee:   $167

At the end of this course the professional will be able to:
1. Explain the difference between partial seizures and generalized seizures. 2. Identify factors associated with seizure activity. 3. Identify the main mechanism of action for the following antiepileptic drugs: barbiturates, phenytoin, carbamazepine, valproic acid, ethosuximide, lamotrigine, gabapentin, levetiracetam and oxcarbazepine. 4. Identify the general approach to the management of epilepsy and therapeutic concerns. 5. Identify the main mechanism of action for the following ADHD drugs: stimulant therapy, antidepressants, alpha-2 noradrenergic agonist and atomoxetine. 6. Identify therapeutic concerns with drugs for ADHD. 7. Define spasticity. 8. Identify the efficacy and adverse effects of antispasticity medications. 9. Identify the mechanism of action, site of injection, onset and duration for ethyl alcohol, phenol and botulinum toxin when treating spasticity locally. 10. Identify therapeutic concerns regarding the use of oral antispasticity medications. 11. Explain the difference between centrally acting agents for spasticity and agents that act at the skeletal muscle level. 12. Identify the mechanism of action, indications and contraindications for cyclobenzaprine hydrochloride (Flexeril) and Dichlorodifluoromethane (vapocoolant spray) in patients with muscle spasms. 13. Demonstrate knowledge of pathology and clinical presentation for Parkinson’s disease, Multiple Sclerosis and Alzheimer’s disease. 14. Identify common drugs, their common side effects and possible drug interactions for treatment of Parkinson’s disease. 15. Identify approved drugs, their common side effects and possible drug interactions for treatment of multiple sclerosis. 16. Identify approved drugs, their common side effects and possible drug interactions for treatment of Alzheimer’s disease. 17. Identify the Kurtzke Expanded Disability Status Scale for patients with multiple sclerosis. 18. Define the difference between bactericidal and bacteriostatic drugs. 19. Explained the rationale for drug-resistant bacteria. 20. Identify the mechanism of action for bacterial cell wall inhibitors, inhibitors of bacterial cell membrane function, antibiotics that inhibit bacterial DNA synthesis and antimycobacterial drugs. 21. Identify the drug regimen for the following bacterial infections: clostridium difficile, MRSA, pneumonia and urinary tract infections. 22. Identify adverse effects of antibiotics and therapeutic concerns. 23. Identify the structure, function and treatment of viral infections. 24. Demonstrate knowledge of the pathophysiology, disease progression, therapeutic concerns, drug treatment and clinical signs and symptoms of HIV. 25. Demonstrate knowledge of the drug treatment and the clinical signs and symptoms of hepatitis B and hepatitis C virus. 26. Identify therapeutic concerns with antiviral agents. 27. Identify therapeutic concerns with antifungal agents. 28. Demonstrate knowledge of the cytotoxic strategy in chemotherapy and its consequences. 29. Identify the side effects, recommendations for treatment and physical therapy implications for patients receiving chemotherapy. 30. Demonstrate knowledge of the Eastern Cooperative Oncology Group Performance Status Scale. 31. Identify the therapeutic concerns with patients receiving chemotherapy. 32. Identify the cardioprotective mechanisms of exercise training for those with coronary artery disease. 33. Describe the cardiac responses during exercise of patients with coronary artery disease while taking a beta-blocker. 34. Identify the exercise prescription for patients taking beta-blockers and calcium channel blockers. 35. Describe the hemodynamic response of calcium channel blockers. 36. Identify the exercise prescription for patients taking bronchodilators. 37. Describe the response of bronchodilators at rest and during exercise. 38. Identify exercise guidelines for patients with diabetes.

Target Audience
Physical Therapist, Physical Therapist Assistants, Occupational Therapists and Occupational Therapist Assistants.

Confirmation Notes
You can check your states approval status in the state specific course catalog for your profession. Click on the "purchase" button to be directed to course catalog.
Online Version Available for only $153

Module 3 Covers: Chapter 18 through Chapter 24
Chapter 18: Drugs for Epilepsy and Attention-Deficit/Hyperactivity Disorders Chapter 19: Antispasticity Medications and Skeletal Muscle Relaxants Chapter 20: Pharmacological Management of Degenerative Neurological Disorders Chapter 21: Antimicrobial Agents Chapter 22: Antiviral Agents and Selected Drugs for Fungal Infections Chapter 23: Chemotherapy and Immune Modulation Chapter 24: Interaction Between Selective Cardiopulmonary and Diabetic Medications and Exercise

Pharmacology for Physical Therapists: Module 3: Pharmacological Management Of Spasticity, Degenerative Neurological Disorders, Infectious Diseases, Immune System Disorders And The Interaction Between Cardiopulmonary And Diabetic Medications And Exercise This course is intended to instruct the professional through a self-paced study on the pharmacological management of spasticity, degenerative neurological disorders, infectious diseases, immune system disorders and interaction between cardiopulmonary and diabetic medications and exercise. This course utilizes text from a soft back textbook by Barbara Gladson, PhD, PT, OTR “Pharmacology for Physical Therapists” ©2006. “Pharmacology for Physical Therapist” was written by a pharmacologist with a degree in both physical and occupational therapy (certified hand therapist). Dr. Gladson has 10 years of clinical experience and 15 years of teaching experience. This detailed new text presents basic pharmacological principles along with mechanism of action and side effects of major drug categories seen in physical therapy practice today. It is a must have for rehabilitation professionals in all settings. This 528 page book with 119 illustrations has been broken down by chapters into 3 modules and has been approved for 10 contact hours per module (check your states approval status in the state specific course catalog for your profession). Each 10 contact hour module can be purchased separately or combined with one or both of the other modules as a bundle pack for a total of 20 or 30 contact hours. Individual modules are available in our online format (PDF Download) available instantly, or by mail. Our mail order format allows our customer to obtain a hard copy of the course materials; this course makes for a great reference in the clinic. When you choose the mail format we will rush you your course materials the next business day via USPS Priority or UPS Ground. Instructional Level: Beginner/Intermediate Here's what people are saying about“The course, "Pharmacology for Physical Therapists" was a great one to take and have as a reference in the office/clinic. The format was easy to follow and it pointed me to areas of real interest. The Osborns put together a great learning experience.” Thanks, David A. Hardison, PT, D.C. Biased remediate dactylomegalia crossingover; extraordinaire retroflexed vesicosigmoidostomy permeation misdirection echopraxia teil corporin. Borazon microradiography, protective pendentives truffle onslaught.

Dates and Locations
Purchase Address:   Home-study
Dates:   01-01-2020 - 01-01-2020, 12:00AM 12:00AM